Molecular and functional mechanisms of right ventricular adaptation in chronic pulmonary hypertension

Annals of Thoracic Surgery

Volumn 67, Issue 4, 1999, Pages 1053-1058

  Chen, Edward P ^a,b   Akhter, Shahab A ^a   Bittner, Hartmuth B ^a   Koch, Walter J ^a   Davis, R Duane ^a   Van Trigt III, Peter ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETERIZATION; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DOG; HEART MUSCLE BIOPSY; HEART RIGHT VENTRICLE FUNCTION; HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECEPTOR DENSITY;

ADAPTATION, PHYSIOLOGICAL; ADENYLATE CYCLASE; ANIMALS; CHRONIC DISEASE; DOGS; HEMODYNAMIC PROCESSES; HYPERTENSION, PULMONARY; MONOCROTALINE; MYOCARDIUM; PULMONARY CIRCULATION; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA; STROKE VOLUME; VENTRICULAR FUNCTION, RIGHT;

EID: 0032942231     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00142-3     Document Type: Article

References (21)

1. Werchan P.M., Summer W.R., Gerdes A.M., McDonough K.H. Right ventricular performance after monocrotaline-induced pulmonary hypertension. Am J Physiol. 256:1989;H1328-H1336.
2. Kramer M.R., Valantine H.A., Marshall S.E., Starnes V.A., Theodore J. Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension. Am J Cardiol. 73:1994;494-500.
3. Chen E.P., Bittner H.B., Craig D.M., Davis R.D. Jr, Van Trigt P. III. Pulmonary hemodynamics and blood flow characteristics in chronic pulmonary hypertension. Ann Thorac Surg. 63:1997;806-813.
4. Mattocks A.R., Jukes R., Brown J. Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids. Toxicon. 27:1989;561-567.
5. Glower D.D., Spratt J.A., Snow N.D., et al. Linearity of the Frank-Starling relationship in the intact heart the concept of preload recruitable stroke work . Circulation. 71:1985;994-1009.
6. Feneley M.P., Elbeery J.R., Gaynor J.W., Gall S.A. Jr, Davis J.W., Rankin J.S. Ellipsoidal shell subtraction model of right ventricular volume. Comparison with regional free wall dimensions as indexes of right ventricular function. Circ Res. 67:1990;1427-1436.
7. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 58:1974;541-548.
8. Koch W.J., Milano C.A., Lefkowitz R.J. Transgenic manipulation of myocardial G protein-coupled receptors and receptor kinases. Circ Res. 78:1996;511-516.
9. Bristow M.R., Kantrowitz N.E., Ginsburg R., Fowler M.B. β-Adrenergic function in heart muscle disease and heart failure. J Mol Cell Cardiol. 17:1985;41-52.
10. Bristow M.R., Minobe W., Rasmussen R., Hershberger R.E., Hoffman B.B. Alpha-1 adrenergic receptors in the nonfailing and failing human heart. J Pharmacol Exp Ther. 247:1988;1039-1045.
11. 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem. 268:1993;15374-15380.
12. 1-adrenergic activity in progression of cardiac hypertrophy in guinea pig hearts with pressure overload. Cardiovasc Res. 23:1989;315-322.
13. 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA. 91:1994;10109-10113.
14. Bristow M.R., Ginsburg R., Minobe W., et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 307:1982;205-211.
15. Bittner H.B., Chen E.P., Milano C.A., et al. Myocardial β-adrenergic receptor function and high-energy phosphates in brain death-related cardiac dysfunction. Circulation. 92:(Suppl 2):1995;472-478.
16. Limas C.J., Limas C. Altered intracellular adrenoceptor distribution in myocardium of spontaneously hypertensive rats. Am J Physiol. 253:1987;H904-H908.
17. Zierhut W., Zimmer H.G. Significance of myocardial α- and β-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circ Res. 65:1989;1417-1425.
18. Roth R.A., Reindel J.F. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite. Adv Exp Med Biol. 283:1991;477-487.
19. Ishikawa S., Honda M., Yamada S., Morioka S., Moriyama K. Biventricular down-regulation of beta-adrenergic receptors in right ventricular hypertrophy induced by monocrotaline. Jpn Circ J. 55:1991;1077-1085.
20. Yoshie H., Tobise K., Onodera S. Intraventricular changes in the β-adrenoreceptor-adenylate cyclase system of the rat heart with the progress of monocrotaline-induced right ventricular hypertrophy. Jpn Circ J. 58:1994;855-865.
21. Kajihara H. Electron microscopic observations of hypertrophied myocardium of rat produced by injection of monocrotaline. Acta Pathol Jpn. 20:1970;183-206.